Literature DB >> 19704342

Increased fluorodeoxyglucose-uptake in positron emission tomography with an endobronchial schwannoma occluding the left main stem bronchus.

Ryota Nakamura1, Shigemi Ishikawa, Mitsuaki Sakai, Yukinobu Goto, Yuko Minami.   

Abstract

A 48-year-old woman suffering from left-side back pain and a 3-year history of coughing was found to have a submucosal lesion occluding the left main bronchus by chest computed tomographic scanning and bronchoscopy. The lesion showed a high standardized uptake value of 3.9 in positron emission tomography with fluorine-18 labeled fluorodeoxyglucose scanning (FDG-PET). The tumor was resected with the posterior wall of the left main bronchus through a postrolateral thoracotomy, and a large defect in the membranous portion was reconstructed in the manner of wedge bronchoplasty, preserving the lung parenchyma. Pathological findings confirmed the diagnosis of schwannoma with no malignant cells. Schwannoma should be included in the differential diagnosis of endobronchial tumors with high standardized uptake values in FDG-PET.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19704342     DOI: 10.1097/JTO.0b013e3181a8cbf4

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  3 in total

1.  Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.

Authors:  Arthur Cho; Jin Hur; Won Jun Kang; Ho Jin Cho; Jae-Hoon Lee; Mijin Yun; Jong Doo Lee
Journal:  Eur Radiol       Date:  2010-11-27       Impact factor: 5.315

2.  Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.

Authors:  Balasubramanian Venkitaraman; Sellam Karunanithi; Arvind Kumar; G C Khilnani; Rakesh Kumar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-17       Impact factor: 9.236

Review 3.  Primary bronchial schwannoma: A case report.

Authors:  Yosuke Aoyama; Atsushi Miyamoto; Takeshi Fujii; Sakashi Fujimori; Meiyo Tamaoka; Daiya Takai
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.